Corbus Pharmaceuticals (NASDAQ:CRBP) reported quarterly losses of $(0.07) per share. This is a 250 percent decrease over losses of $(0.02) per share from the same period last year.
L3Harris Viper Shield Electronic Warfare System Awarded Long-Lead Material Contract To Accelerate Global Production; No Financial Terms Disclosed
Highlights:
Ensures rapid delivery of Viper Shield systems to partner nations
Minimizes procurement risks and protects planned production deliveries
Will improve aircraft protection to safely complete
